Topical Drug Delivery Market, By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products) By Route of Administration, By End-User, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2027

Report
118 Pages
July 2022
Region: Global
TechSci Research
ID: 5633001

The global topical drug delivery market is anticipated to witness a growth with a steady CAGR in the forecast period, 2023-2027. Factors such as increased incidence of burn injuries across the globe and advancements in the transdermal drug delivery systems are primarily driving the market demand. The rise at the old age population who prefer to use tropical drug delivery as it eases the drug delivery process fuels the market demand. Also, the growing popularity of the non-invasive procedures due to their cost-effectiveness and fast healing among patients is further expected to influence the market growth in the next five years.

The global topical drug delivery market is segmented into product, route of administration, end user, distribution channel, regional distribution, and Competitive Landscape. Based on product, the market is fragmented into semi-solid formulations, liquid formulations, solid formulations, and transdermal products. Semi-solid formulations dominate the market and are anticipated to maintain their dominance over the forecast period, 2023-2027. Lotions, creams, gels, pastes, ointments, and other semi-solid formulations are some examples of semi-solid formulations that are used topically. These formulations are absorbed through the skin, and the therapeutic ingredients do the same, penetrating the skin to enter the body's bloodstream through tiny capillaries. They fix any damage or abnormality in the epidermal tissues that cover the surface of the body. The rise in the number of surgeries and organ transplantation procedures is driving the segment demand.

The major market players operating in the global topical drug delivery market are Johnson & Johnson SA, Nestlé SA, GlaxoSmithKline Plc, Novartis AG, Merck & Co. Inc., Crescita Therapeutics Inc., Cipla Ltd., Taro Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Glenmark Pharmaceuticals Ltd., Bayer AG, Encore Dermatology, Inc., MedPharm Group Ltd., Skinvisible Pharmaceuticals, Inc., and Galderma S.A.

Years considered for this report:

Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F-2027F

Objective of the Study:

To analyze the historical growth in the market size of global topical drug delivery market from 2017 to 2021.
To estimate and forecast the market size of global topical drug delivery market from 2022E to 2027F and growth rate until 2027F.
To classify and forecast global topical drug delivery market based on product, route of administration, end user, distribution channel, regional distribution, and competitional landscape.
To identify dominant region or segment in the global topical drug delivery market.
To identify drivers and challenges for global topical drug delivery market.
To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global topical drug delivery market.
To identify and analyze the profile of leading players operating in global topical drug delivery market.
To identify key sustainable strategies adopted by market players in global topical drug delivery market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of companies, suppliers, and service providers across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the companies, which could not be identified due to the limitations of secondary research. The publisher analyzed the presence of all major players across the globe.

The publisher calculated the market size of global topical drug delivery market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the publisher.

Key Target Audience:

End users, service providers and other stakeholders
Distributers and suppliers of topical drugs and other stakeholders
Organizations, forums, and alliances related to topical drug delivery market
Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vendors, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global Topical Drug Delivery market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Topical Drug Delivery Market, By Product:

Semi-Solid Formulations
Liquid Formulations
Solid Formulations
Transdermal Products

Global Topical Drug Delivery Market, By Route of Administration:

Dermal Drug Delivery
Ophthalmic Drug Delivery
Rectal Drug Delivery
Vaginal Drug Delivery
Nasal Drug Delivery

Global Topical Drug Delivery Market, By Distribution Channel:

Online
Offline

Global Topical Drug Delivery Market, By End User:

Hospitals
Clinics
Home Healthcare
Diagnostic Centers
Others

Global Topical Drug Delivery Market, By Region:

North America

United States
Canada
Mexico

Europe

Germany
France
United Kingdom
Italy
Spain

Asia-Pacific

China
Japan
India
South Korea
Australia

Middle East & Africa

South Africa
Saudi Arabia
UAE

South America

Brazil
Argentina
Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global topical drug delivery market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

1. Product Overview2. Research Methodology3. Executive Summary4. Impact of COVID-19 on Global Topical Drug Delivery Market5. Voice of Customer

6. Global Topical Drug Delivery Market Outlook

6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Semi-Solid Formulations, Liquid Formulations, Solid Formulations, Transdermal Products)
6.2.2. By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery)
6.2.3. By End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others)
6.2.4. By Distribution Channel (Online vs. Offline)
6.2.5. By Company (2021)
6.2.6. By Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
6.3. Product Market Map

7. North America Topical Drug Delivery Market Outlook

7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Route of Administration
7.2.3. By End User
7.2.4. By Distribution Channel
7.2.5. By Country (United States; Canada; Mexico)
7.3. North America: Country Analysis
7.3.1. United States Topical Drug Delivery Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By End User
7.3.1.2.4. By Distribution Channel
7.3.2. Canada Topical Drug Delivery Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By End User
7.3.2.2.4. By Distribution Channel
7.3.3. Mexico Topical Drug Delivery Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By End User
7.3.3.2.4. By Distribution Channel

8. Europe Topical Drug Delivery Market Outlook

8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Route of Administration
8.2.3. By End User
8.2.4. By Distribution Channel
8.2.5. By Country (France; Germany; UK; Italy; Spain)
8.3. Europe: Country Analysis
8.3.1. France Topical Drug Delivery Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By End User
8.3.1.2.4. By Distribution Channel
8.3.2. Germany Topical Drug Delivery Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By End User
8.3.2.2.4. By Distribution Channel
8.3.3. United Kingdom Topical Drug Delivery Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By End User
8.3.3.2.4. By Distribution Channel
8.3.4. Italy Topical Drug Delivery Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By End User
8.3.4.2.4. By Distribution Channel
8.3.5. Spain Topical Drug Delivery Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By End User
8.3.5.2.4. By Distribution Channel

9. Asia-Pacific Topical Drug Delivery Market Outlook

9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Route of Administration
9.2.3. By End User
9.2.4. By Distribution Channel
9.2.5. By Country (China; India; Japan; South Korea; Australia)
9.3. Asia Pacific: Country Analysis
9.3.1. China Topical Drug Delivery Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By End User
9.3.1.2.4. By Distribution Channel
9.3.2. India Topical Drug Delivery Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By End User
9.3.2.2.4. By Distribution Channel
9.3.3. Japan Topical Drug Delivery Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By End User
9.3.3.2.4. By Distribution Channel
9.3.4. South Korea Topical Drug Delivery Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Route of Administration
9.3.4.2.3. By End User
9.3.4.2.4. By Distribution Channel
9.3.5. Australia Topical Drug Delivery Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Route of Administration
9.3.5.2.3. By End User
9.3.5.2.4. By Distribution Channel

10. Middle East and Africa Topical Drug Delivery Market Outlook

10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Route of Administration
10.2.3. By End User
10.2.4. By Distribution Channel
10.2.5. By Country (UAE; Saudi Arabia; South Africa)
10.3. MEA: Country Analysis
10.3.1. South Africa Topical Drug Delivery Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By End User
10.3.1.2.4. By Distribution Channel
10.3.2. Saudi Arabia Topical Drug Delivery Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By End User
10.3.2.2.4. By Distribution Channel
10.3.3. UAE Topical Drug Delivery Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By End User
10.3.3.2.4. By Distribution Channel

11. South America Topical Drug Delivery Market Outlook

11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Route of Administration
11.2.3. By End User
11.2.4. By Distribution Channel
11.2.5. By Country (Brazil; Argentina; Colombia)
11.3. South America: Country Analysis
11.3.1. Brazil Topical Drug Delivery Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Route of Administration
11.3.1.2.3. By End User
11.3.1.2.4. By Distribution Channel
11.3.2. Argentina Topical Drug Delivery Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Route of Administration
11.3.2.2.3. By End User
11.3.2.2.4. By Distribution Channel
11.3.3. Colombia Topical Drug Delivery Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Route of Administration
11.3.3.2.3. By End User
11.3.3.2.4. By Distribution Channel

12. Market Dynamics

12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1. Competition Outlook
14.2. Global Players Profiled (Leading Companies)
14.2.1. Johnson & Johnson SA
14.2.2. Nestlé SA
14.2.3. GlaxoSmithKline Plc
14.2.4. Novartis AG
14.2.5. Merck & Co. Inc.
14.2.6. Crescita Therapeutics Inc.
14.2.7. Cipla Ltd.
14.2.8. Taro Pharmaceutical Industries Ltd.
14.2.9. Valeant Pharmaceuticals International Inc.
14.2.10. Glenmark Pharmaceuticals Ltd.
14.2.11. Bayer AG
14.2.12. Encore Dermatology, Inc.
14.2.13. MedPharm Group Ltd.
14.2.14. Skinvisible Pharmaceuticals, Inc.
14.2.15. Galderma S.A.

15. Strategic Recommendations

Companies Mentioned

Johnson & Johnson SA
Nestlé SA
GlaxoSmithKline Plc
Novartis AG
Merck & Co Inc
Crescita Therapeutics Inc
Cipla Ltd
Taro Pharmaceutical Industries Ltd
Valeant Pharmaceuticals International Inc
Glenmark Pharmaceuticals Ltd
Bayer AG
Encore Dermatology, Inc
MedPharm Group Ltd
Skinvisible Pharmaceuticals, Inc
Galderma SA

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4418EUR$4,500USD£3,674GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5400EUR$5,500USD£4,490GBP